Cover Image

Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promising therapeutic approach with chiauranib, a novel o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuanfang Tang (Author), Mengya Zhong (Author), Guangchao Pan (Author), Jinshui Tan (Author), Chendi Xie (Author), Yuelong Jiang (Author), Jingwei Yao (Author), Weihang Shan (Author), Jiaqi Lin (Author), Jiewen Huang (Author), Yating Liu (Author), Zhifeng Li (Author), Bing Xu (Author), Jie Zha (Author)
Format:	Book
Published:	MDPI AG, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
by: Fa Jin, et al.
Published: (2018)

3,4-Difluorobenzocurcumin Inhibits Vegfc-Vegfr3-Erk Signalling to Block Developmental Lymphangiogenesis in Zebrafish
by: Kazuhide S. Okuda, et al.
Published: (2021)

Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival
by: Masaharu Noi, et al.
Published: (2020)

Crocetin and Its Glycoside Crocin, Two Bioactive Constituents From Crocus sativus L. (Saffron), Differentially Inhibit Angiogenesis by Inhibiting Endothelial Cytoskeleton Organization and Cell Migration Through VEGFR2/SRC/FAK and VEGFR2/MEK/ERK Signaling Pathways
by: Chen Zhao, et al.
Published: (2021)

Reduced expression of PD-L1 in autoimmune thyroiditis attenuate trophoblast invasion through ERK/MMP pathway
by: Mengya Chen, et al.
Published: (2019)

A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities
by: Mohadeseh Namjoo, et al.
Published: (2023)

miR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia
by: Jasenka Guduric-Fuchs, et al.
Published: (2021)

Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor
by: Vinod Anera Balakrishna, et al.
Published: (2017)

Immunohistochemical study of VEGF-A, VEGFR-1, VEGFR-2 and CD34 expression in сolorectal adenocarcinoma progression
by: M. A. Shyshkin
Published: (2019)

Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells
by: Weich Herbert A, et al.
Published: (2005)

Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study
by: Euno Choi, et al.
Published: (2018)

Magnoliae flos Downregulated Lipopolysaccharide-Induced Inflammatory Responses via NF-κB/ERK-JNK MAPK/STAT3 Pathways
by: Tae-Young Gil, et al.
Published: (2022)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus
by: Ewa Robak, et al.
Published: (2003)

Porocarcinoma in situ showing follicular differentiation: A case report
by: Chia-Lan Ou, et al.
Published: (2012)

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells
by: Yuelong Jiang, et al.
Published: (2022)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
by: Zongru Jiang, et al.
Published: (2020)

Role of VEGF-VEGFR2 signaling pathway in psoriasis
by: Xiaomei LUO, et al.
Published: (2022)

Structure-Based Design of Peptides Targeting VEGF/VEGFRs
by: Rossella Di Stasi, et al.
Published: (2023)

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
by: Hideki Amano, et al.
Published: (2021)

Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3
by: Wei Xie, et al.
Published: (2018)

Small-Dose Sunitinib Modulates p53, Bcl-2, STAT3, and ERK1/2 Pathways and Protects against Adenine-Induced Nephrotoxicity
by: Mohamed A. Saleh, et al.
Published: (2020)

The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
by: Gurhan Guney, et al.
Published: (2022)

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway
by: Yang Bai, et al.
Published: (2022)

Inhibition of JAK-STAT ERK/MAPK and Glycogen Synthase Kinase-3 Induces a Change in Gene Expression Profile of Bovine Induced Pluripotent Stem Cells
by: Luis F. Malaver-Ortega, et al.
Published: (2016)

<it>In vivo </it>monitoring of fetoplacental Vegfr2 gene activity in a murine pregnancy model using a Vegfr2-luc reporter gene and bioluminescent imaging
by: Rude Brian J, et al.
Published: (2011)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
by: Jia Li, et al.
Published: (2019)

The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones
by: Perikles Kosmidis, et al.
Published: (2018)

Corrigendum to "Modulation of the JAK/ERK/STAT signaling in melanocortin -induced inhibition of local and systemic responses to myocardial ischemia/reperfusion [Pharmacological Research 72 (2013) 1-8]
by: Alessandra Ottani, et al.
Published: (2023)

Human follicular fluid shows diverse metabolic profiles at different follicle developmental stages
by: Jihong Yang, et al.
Published: (2020)

Comparison of small molecules VEGFR inhibitors in the treatment of renal cell carcinoma
by: Jie Yi Tan, et al.
Published: (2023)

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024)

VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment
by: Jana Jaal, et al.
Published: (2015)

Basaloid follicular hamartoma associated with follicular mucinosis and inflammation
by: Solange Edelman, et al.
Published: (2022)

Targeting STAT3 and STAT5 in Cancer
Published: (2020)

Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases
by: Jiadong Li, et al.
Published: (2022)

Follicular mucinosis
by: Marie Lewars, et al.
Published: (2013)

PKD3 promotes metastasis and growth of oral squamous cell carcinoma through positive feedback regulation with PD-L1 and activation of ERK-STAT1/3-EMT signalling
by: Bomiao Cui, et al.
Published: (2021)

SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model
by: Jihong Jiang, et al.
Published: (2020)

Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways
by: Kenji Ichikawa, et al.
Published: (2016)

CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS
by: E. A. Kim, et al.
Published: (2014)